EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Embrace Pain —A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy‐Induced Peripheral Neuropathy in Cancer Survivors

Daniëlle L van de Graaf iD, Paul Lodder iD, Tom Smeets iD, Marije L van der Lee iD, Hester R Trompetter, Karlein M G Schreurs, Elin Børøsund iD, Lise Solberg Nes iD, Floortje Mols iD

Psycho-Oncology · 2026

DOI: 10.1002/pon.70608 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psycho-Oncology, 2026. Verfasst von Daniëlle L van de Graaf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Psychology, CoRPS-Center of Research on Psychological Disorders and Somatic Diseases, Tilburg University, Tilburg,…. Hauptthemen laut MEDLINE: Acceptance and Commitment Therapy, Peripheral Nervous System Diseases, Cancer Survivors, Antineoplastic Agents. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common and persistent side effect of chemotherapy, with up to 30% of patients reporting symptoms 6 months post‐treatment. Painful CIPN can impair sleep, mood, and physical functioning. We evaluated “Embrace Pain,” an online Acceptance and Commitment Therapy (ACT) based self‐help intervention that may be of support for cancer survivors with chronic painful CIPN.

Methods

The Embrace Pain Randomized Controlled Trial (RCT) compared ACT with a waiting list condition (WLC) using a two‐armed randomized design. Adults (≥ 18 years) with painful CIPN ≥ 6 months post‐chemotherapy were randomized to an 8‐week guided online ACT program or WLC. Primary outcome was pain interference (Multidimensional Pain Inventory, MPI). Secondary outcomes included pain catastrophizing, psychological flexibility, CIPN severity, pain intensity, and quality of life (QoL). Linear mixed models and criteria for clinically significant change were used to evaluate outcomes from baseline to 3‐month follow‐up.

Results

112 participants were included (57 ACT, 55 WLC). No significant treatment effect was observed for the primary outcome, pain interference, with ACT not outperforming the WLC over time. However, more ACT participants showed clinically significant improvement in pain interference at 3‐month follow‐up (47.4% vs. 23.6%) than WLC participants, and exploratory analyses showed greater reductions in pain catastrophizing in the ACT group. No between‐group differences were found for psychological flexibility, CIPN severity, pain intensity, or QoL.

Discussion

Online ACT did not demonstrate a significant treatment effect on pain interference in those with painful CIPN. Exploratory findings suggest potential benefits for pain catastrophizing and clinically meaningful improvement in pain interference for some participants. Larger studies are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acceptance and Commitment TherapyPeripheral Nervous System DiseasesCancer SurvivorsAntineoplastic AgentsNeoplasmsHumansFemaleMiddle AgedMaleQuality of LifeAgedAdultPain MeasurementTreatment OutcomeCatastrophizationPain

Stichwörter der Autor:innen

acceptance and commitment therapy (ACT)cancer survivorshipchemotherapy‐induced peripheral neuropathy (CIPN)online self‐help interventionpain interference

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical and Clinical Psychology, CoRPS-Center of Research on Psychological Disorders and Somatic Diseases, Tilburg University, Tilburg, the Netherlands.
  • Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, the Netherlands.
  • Department of Methodology and Statistics, Tilburg University, Tilburg, the Netherlands.
  • Centre for Psycho-Oncology, Scientific Research Department, Helen Dowling Institute, Bilthoven, the Netherlands.
  • Department of Psychology, Health & Technology, Centre for eHealth & Well-being Research, University of Twente, Enschede, the Netherlands.
  • Department of Digital Health Research, Division of Medicine, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Daniëlle L van de Graaf, Paul Lodder, Tom Smeets, Marije L van der Lee, Elin Børøsund, Lise Solberg Nes, Floortje Mols

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

van de Graaf, D. L., Lodder, P., Smeets, T., van der Lee, M. L., Trompetter, H. R., Schreurs, K. M. G., Børøsund, E., Nes, L. S., & Mols, F. (2026). Embrace Pain —A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy‐Induced Peripheral Neuropathy in Cancer Survivors. Psycho-Oncology. https://doi.org/10.1002/pon.70608

Vancouver

van de Graaf DL, Lodder P, Smeets T, van der Lee ML, Trompetter HR, Schreurs KMG, et al. Embrace Pain —A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy‐Induced Peripheral Neuropathy in Cancer Survivors. Psycho-Oncology. 2026. doi:10.1002/pon.70608

BibTeX
@article{vandeGraaf2026,
  author = {van de Graaf, Daniëlle L and Lodder, Paul and Smeets, Tom and van der Lee, Marije L and Trompetter, Hester R and Schreurs, Karlein M G and Børøsund, Elin and Nes, Lise Solberg and Mols, Floortje},
  title = {Embrace Pain —A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy‐Induced Peripheral Neuropathy in Cancer Survivors},
  journal = {Psycho-Oncology},
  year = {2026},
  doi = {10.1002/pon.70608}
}
Kostenlos starten →